Axela Biosensors Inc. Acquires Exclusive License to Broad IP Portfolio From Kimberly-Clark Corp.
Axela Biosensors Inc. announced that it has completed a significant exclusive in-licensing agreement with Kimberly-Clark Corp. The agreement includes exclusive rights to approximately 150 world-wide patents and applications, as well as transfer of significant immunodiagnostics assay technology. As part of the agreement, Kimberly-Clark will also be acquiring an equity interest in Axela. Axela was first identified as a license partner for Kimberly-Clark's diffraction based biosensor technology by yet2.com. The terms of the agreement were not disclosed.
